Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
corporation source : Www.daxor.com save search
Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference
Published: 2022-03-23 (Crawled : 12:30) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
| Email alert
Add to watchlist
conference corporation growth group
Daxor Corporation CEO & President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
Published: 2022-03-01 (Crawled : 14:00) - daxor.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 3.34%
H: 0.0%
C: 0.0%
ceo corporation
Daxor Corporation Announces $1.35 Per Share NAV Increase and Files Annual Report for Fiscal 2021
Published: 2022-03-01 (Crawled : 13:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
| Email alert
Add to watchlist
ces corporation report
Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Assessment of Heart Failure
Published: 2022-02-17 (Crawled : 14:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: -0.67%
bva-100 100 diagnostic blood heart
Daxor Corporation Commences Trading on The NASDAQ Capital Market
Published: 2022-02-02 (Crawled : 13:30) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: -1.08%
H: 0.0%
C: 0.0%
nasdaq corporation
Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors
Published: 2022-01-22 (Crawled : 04:20) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
| Email alert
Add to watchlist
corporation
Daxor Corporation to Commence Trading on The Nasdaq Capital Market
Published: 2022-01-20 (Crawled : 22:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.76%
nasdaq corporation
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Published: 2022-01-06 (Crawled : 13:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 2.21%
H: 0.0%
C: -0.43%
conference corporation
Daxor Announces Key Milestones Achieved for Multicenter BVA-100® Study in Hospitalized Patients With COVID-19
Published: 2022-01-05 (Crawled : 13:30) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 0.36%
H: 0.62%
C: 0.62%
bva-100 100 covid-19 covid milestone
Daxor Awarded New Patent for Blood Volume Guidance Technology to Improve Treatment & Outcomes
Published: 2022-01-04 (Crawled : 13:30) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 0.91%
H: 0.81%
C: 0.81%
treatment blood patent technology
Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Optimal Heart Failure Management at Key Scientific Society Meeting
Published: 2021-11-16 (Crawled : 13:30) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: -0.84%
H: 3.19%
C: 3.18%
blood heart dating test
New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100®) Diagnostic in Neurocritical Care
Published: 2021-11-09 (Crawled : 14:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: -1.6%
blood research diagnostic
Daxor Corporation Receives $200K Matching Fund Award From Launch Tennessee
Published: 2021-10-01 (Crawled : 13:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: -4.25%
awards
Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at Key Scientific Society Meeting
Published: 2021-09-14 (Crawled : 13:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 0.64%
H: 4.57%
C: 2.95%
blood heart dating test
Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021
Published: 2021-09-08 (Crawled : 14:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: -2.52%
H: 6.29%
C: 2.78%
blood heart clinical trials test trials trial
Daxor’s Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill COVID-19 Patients In Newly Published Data in Journal Critical Care
Published: 2021-08-04 (Crawled : 13:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 4.45%
H: 8.51%
C: -2.98%
covid blood diagnostic
Daxor Corporation Announces Non-Government Distribution Agreement with Concordance® Healthcare Solutions
Published: 2021-07-22 (Crawled : 13:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 0.58%
H: 29.67%
C: -2.3%
distribution
American College of Cardiology (ACC) Features Expert Analysis on the Importance of Addressing Anemia With Blood Volume Analysis in Heart Failure Patients
Published: 2021-07-13 (Crawled : 13:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: -1.65%
H: 11.52%
C: -0.93%
blood heart cardiology anemia cardio
Daxor Corporation Receives National Institutes of Health (NIH) Funding Notification for Landmark Multi-Center Heart Failure Trial Utilizing the BVA-100® (Blood Volume Analyzer) with the United States Department of Veterans Affairs
Published: 2021-05-06 (Crawled : 12:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 6.38%
H: 0.0%
C: -5.84%
funding blood heart trial
Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Assessment of Postural Tachycardia Syndrome (POTS)
Published: 2021-04-30 (Crawled : 02:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.31%
blood syndros diagnostic
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.